1. Home
  2. PCH vs FOLD Comparison

PCH vs FOLD Comparison

Compare PCH & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PotlatchDeltic Corporation

PCH

PotlatchDeltic Corporation

HOLD

Current Price

$40.80

Market Cap

3.0B

Sector

Real Estate

ML Signal

HOLD

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$9.83

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCH
FOLD
Founded
1903
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.1B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
PCH
FOLD
Price
$40.80
$9.83
Analyst Decision
Hold
Buy
Analyst Count
6
7
Target Price
$45.67
$30.29
AVG Volume (30 Days)
508.7K
4.2M
Earning Date
01-26-2026
11-04-2025
Dividend Yield
4.42%
N/A
EPS Growth
312.61
N/A
EPS
0.82
N/A
Revenue
$1,115,571,000.00
$598,704,000.00
Revenue This Year
$3.38
$21.49
Revenue Next Year
$1.91
$18.25
P/E Ratio
$49.63
N/A
Revenue Growth
5.40
21.28
52 Week Low
$36.82
$5.51
52 Week High
$48.12
$10.57

Technical Indicators

Market Signals
Indicator
PCH
FOLD
Relative Strength Index (RSI) 56.73 60.26
Support Level $39.02 $9.73
Resistance Level $40.14 $10.05
Average True Range (ATR) 0.94 0.33
MACD 0.24 -0.04
Stochastic Oscillator 69.86 40.87

Price Performance

Historical Comparison
PCH
FOLD

About PCH PotlatchDeltic Corporation

PotlatchDeltic Corp is a REIT that owns and manages forestland in Alabama, Arkansas, Idaho, Minnesota, and Mississippi. Potlach operates in three segments. The timberlands segment covers the planting and harvesting of trees, as well as the construction and maintenance of roads. The wood products segment manufactures and distributes lumber, plywood, and other wood products. The real estate segment covers the sales generated from company-owned timberlands, as well as commercial and residential properties. The timberlands and the wood product segments combined drive the majority of the company's revenue.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: